Table 3.

Associations between ESRD and prostate cancer, by stage at cancer diagnosis and PSA screening

Prostate cancer outcome	Number of cases	Association with ESRD, odds ratio (95% CI)
		Overall	PSA in 1 year before diagnosis/selection	No PSA in 1 year before diagnosis/selection
All cancers	193,632	0.42 (0.35, 0.50)	0.52 (0.39, 0.71)	0.52 (0.42, 0.66)
By stage
Localized/regional	136,904	0.34 (0.28, 0.41)	0.45 (0.33, 0.62)	0.42 (0.31, 0.55)
Distant/metastic	8,333	0.89 (0.62, 1.26)	0.98 (0.54, 1.79)	0.95 (0.61, 1.48)
Unstaged	8,302	0.84 (0.58, 1.22)	1.12 (0.66, 1.89)	0.91 (0.50, 1.66)

Abbreviations: ESRD end-stage renal disease, CI confidence interval, PSA prostate specific antigen test.